A generic alternative indicated for neurology. Neurological pathway modulation assists in stabilizing motor control and alleviating rigid physical symptoms.
An antiviral and antiparkinsonian agent intended to manage motor symptoms and designed to alleviate fatigue to support neurological function in Parkinson's disease.
Mechanism of Action
It works as a weak NMDA antagonist and increases dopamine release while inhibiting its reuptake. For influenza, it prevents viral uncoating and release.
Route of Administration
Oral
Onset Time
48 hours (motor symptoms)
Duration
12–24 hours
Contraindications
Severe kidney disease, Untreated angle-closure glaucoma, Allergy to amantadine
Information for Amantadine is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
